Effects of Allopurinol on the Progression of Chronic Kidney Disease - Badve, Sunil V; Pascoe, Elaine M; Tiku, Anushree; Boudville, Neil; Brown, Fiona G; Cass, Alan; Clarke, Philip; Dalbeth, Nicola; Day, Richard O; de Zoysa, Janak R; Douglas, Bettina; Faull, Randall; et al. (The New England journal of medicine, 2020)
Keywords: Aged; Albumin; Allopurinol; Allopurinol - adverse effects; Allopurinol - therapeutic use; Clinical trials; Confidence intervals; Creatinine; Design; Diabetes Mellitus, Type 1 - blood; Diabetes Mellitus, Type 1 - drug therapy; Diabetes Mellitus, Type 1 - physiopathology; Diabetic Nephropathies - drug therapy; Diabetic Nephropathies - physiopathology; Disease Progression; Double-Blind Method; Drug dosages; Enzyme Inhibitors - adverse effects; Enzyme Inhibitors - therapeutic use; Epidemiology; Epidermal growth factor receptors; Female; Glomerular filtration rate; Glomerular Filtration Rate - drug effects; Gout; Gout Suppressants - adverse effects; Gout Suppressants - therapeutic use; Humans; Kidney diseases; Male; Medical research; Middle Aged; Patients; Renal Insufficiency, Chronic - drug therapy; Renal Insufficiency, Chronic - physiopathology; Renin-Angiotensin System; Treatment Failure; Uric acid; Uric Acid - blood; Xanthine Oxidase - antagonists & inhibitors; New Zealand; Australia